Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,159 | 32,640 | 44,543 | 59,752 | 27,413 |
| Receivables | 1,932 | 1,879 | 3,031 | 3,280 | 1,833 |
| Inventories | 1,356 | 213 | 784 | 621 | 528 |
| Other current assets | 0 | 0 | 0 | 0 | 1,128 |
| TOTAL | $25,752 | $38,352 | $56,975 | $70,914 | $40,189 |
| Non-Current Assets | |||||
| PPE Net | 3,440 | 2,487 | 1,276 | 676 | 713 |
| Intangibles | 55,847 | 69,747 | 69,747 | 83,057 | 83,057 |
| Other Non-Current Assets | 365 | 522 | 512 | 708 | 871 |
| TOTAL | $59,652 | $72,756 | $71,535 | $84,441 | $84,641 |
| Total Assets | $85,404 | $111,108 | $128,510 | $155,355 | $124,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 57,748 | 4,150 | 1,432 | N/A | 607 |
| Accounts payable and accrued liabilities | 2,530 | 2,630 | 2,407 | 7,003 | 5,437 |
| Accrued Expenses | 7,857 | 9,268 | 15,395 | 13,949 | 11,947 |
| TOTAL | $68,392 | $16,408 | $19,723 | $21,484 | $18,555 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12 | 53,039 | 18 | 20 | N/A |
| Other Non-Current Liabilities | 649 | 1,574 | 2,115 | 9,216 | 4,690 |
| TOTAL | $686 | $54,700 | $57,694 | $65,325 | $47,764 |
| Total Liabilities | $69,078 | $71,108 | $77,417 | $86,809 | $66,319 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,535 | 99,350 | 99,350 | 99,154 | 99,150 |
| Common Shares | 994 | 993 | 992 | 992 | 836 |
| Retained earnings | -604,723 | -580,834 | -569,222 | -550,903 | -536,457 |
| TOTAL | $16,326 | $40,000 | $51,093 | $68,546 | $58,511 |
| Total Liabilities And Equity | $85,404 | $111,108 | $128,510 | $155,355 | $124,830 |